|1.||Reilly, Raymond M: 1 article (07/2013)|
|2.||Kahn, Harriette J: 1 article (07/2013)|
|3.||Holloway, Claire M B: 1 article (07/2013)|
|4.||Caldwell, Curtis B: 1 article (07/2013)|
|5.||Scollard, Deborah A: 1 article (07/2013)|
|6.||Ehrlich, Lisa: 1 article (07/2013)|
|7.||Sluiter, W J: 1 article (09/2007)|
|8.||Gietema, J A: 1 article (09/2007)|
|9.||de Korte, M A: 1 article (09/2007)|
|10.||Sleijfer, D T: 1 article (09/2007)|
05/20/2006 - "On the first scan, myocardial 111In-DTPA-trastuzumab uptake was observed in one patient with pre-existing cardiac arrhythmias, who did not develop heart failure during treatment. "
09/01/2007 - "To evaluate whether myocardial HER2 expression is upregulated by anthracycline-induced cardiac stress or in case of heart failure by chronic pressure or volume overload, we performed 111In-DTPA-trastuzumab scans in patients shortly after anthracyclines and with non-anthracycline-related heart failure. "
09/01/2007 - "Patients within 3 weeks after undergoing 4-6 cycles first-line anthracycline-based chemotherapy and patients with heart failure due to cardiac disease underwent gammacamera imaging 48 and 96 h after 111In-DTPA-trastuzumab intravenously. "
|4.||Heart Diseases (Heart Disease)
|5.||Cardiac Arrhythmias (Arrythmia)
|1.||Immunoglobulin Fab Fragments
|1.||Drug Therapy (Chemotherapy)